Family 1

Mindset Pharma (MSET.C) announced their lead clinical candidate, MSP-1014. MSP-1014 is a differentiated psilocybin-based compound from Mindset’s Family 1 of novel, patent-pending psychedelic compounds. MSET plans on moving forward…